December 22, 2014
The FDA has approved a new combination antibiotic for the treatment of complicated intra-abdominal infections and complicated urinary tract infections in adults.
Ceftolozane/tazobactam (Zerbaxa, Cubist) contains a cephalosporin and a beta-lactamase inhibitor. Used alone, it can treat complicated UTIs, including pyelonephritis. It can also be used in combination with metronidazole to treat complicated intra-abdominal infections